Gene · 6788
Papers1,840
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,840
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetics: Novel crucial approach for osteogenesis of mesenchymal stem cells. | J Tissue Eng | 2023 | 37342486 | PubTator, text mining | PubMed |
| Identifying the role of NUDCD1 in human tumors from clinical and molecular mechanisms: a study based on comprehensive bioinformatics and experimental validation. | Aging (Albany NY) | 2023 | 37338527 | PubTator, text mining | PubMed |
| Urolithin A exhibits a neuroprotective effect against Alzheimer's disease by inhibiting DYRK1A activity. | J Food Drug Anal | 2023 | 37335158 | PubTator, text mining | PubMed |
| Chaetocin exhibits anticancer effects in esophageal squamous cell carcinoma via activation of Hippo pathway. | Aging (Albany NY) | 2023 | 37319316 | PubTator, text mining | PubMed |
| Elraglusib (formerly 9-ING-41) possesses potent anti-lymphoma properties which cannot be attributed to GSK3 inhibition. | Cell Commun Signal | 2023 | 37316860 | PubTator, text mining | PubMed |
| MST4 promotes proliferation, invasion, and metastasis of gastric cancer by enhancing autophagy. | Heliyon | 2023 | 37313160 | PubTator, text mining | PubMed |
| Low MST1/2 and negative LATS1/2 expressions are associated with poor prognosis of colorectal cancers. | Pathol Res Pract | 2023 | 37302275 | PubTator, text mining | PubMed |
| How Driver Oncogenes Shape and Are Shaped by Alternative Splicing Mechanisms in Tumors. | Cancers (Basel) | 2023 | 37296881 | PubTator, text mining | PubMed |
Underexplored reciprocity between genome-wide methylation status and long non-coding RNA expression reflected in breast cancer research: potential impacts for the disease management in the framework of 3P medicine. | EPMA J | 2023 | 37275549 | PubTator, text mining | PubMed |
| Epigenome-wide DNA methylation analysis of myasthenia gravis. | FEBS Open Bio | 2023 | 37254650 | PubTator, text mining | PubMed |
| Comprehensive analysis and molecular map of Hippo signaling pathway in lower grade glioma: the perspective toward immune microenvironment and prognosis. | Front Oncol | 2023 | 37251938 | PubTator, text mining | PubMed |
| The hippo kinases MST1/2 in cardiovascular and metabolic diseases: A promising therapeutic target option for pharmacotherapy. | Acta Pharm Sin B | 2023 | 37250161 | PubTator, text mining | PubMed |
| Arrhythmogenic cardiomyopathy as a myogenic disease: highlights from cardiomyocytes derived from human induced pluripotent stem cells. | Front Physiol | 2023 | 37250123 | PubTator, text mining | PubMed |
| LncRNA FAM83A-AS1 promotes epithelial-mesenchymal transition of pancreatic cancer cells via Hippo pathway. | Cell Cycle | 2023 | 37245082 | PubTator, text mining | PubMed |
| Activating the Hippo pathway by nevadensin overcomes Yap-drived resistance to sorafenib in hepatocellular carcinoma. | Discov Oncol | 2023 | 37243813 | PubTator, text mining | PubMed |
| Molecular mechanisms involved in regulating protein activity and biological function of MST3. | Cell Div | 2023 | 37202821 | PubTator, text mining | PubMed |
| Deciphering the involvement of the Hippo pathway co-regulators, YAP/TAZ in invadopodia formation and matrix degradation. | Cell Death Dis | 2023 | 37185904 | PubTator, text mining | PubMed |
| STK24 Promotes Progression of LUAD and Modulates the Immune Microenvironment. | Mediators Inflamm | 2023 | 37181807 | PubTator, text mining | PubMed |
| NF2 alteration in mesothelioma. | Front Toxicol | 2023 | 37180489 | PubTator, text mining | PubMed |
| Proteomic characteristics reveal the signatures and the risks of T1 colorectal cancer metastasis to lymph nodes. | Elife | 2023 | 37158593 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6788/papers?page=9